Skip to content

Author

S. Ryozawa

We have 3 of 308 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Underestimation of Subserosal Invasion in Early Gastric Cancer‐Like Advanced Gastric Carcinoma With Focal Enteroblastic Differentiation: A Case Report

ABSTRACT Early gastric cancer (EGC)‐like advanced gastric cancer (AGC) is a rare entity that mimics superficial disease despite deep invasion. We report a case of EGC‐like AGC with focal enteroblastic differentiation in which subserosal invasion was underestimated because of its superficially appearing endoscopic featu...

Akira Tomioka, Kankei Fujimoto, Kei Sugimoto et al. · 0 citations
Review Jul 2026

Efficacy and Safety of Remimazolam versus Midazolam for Sedation during Endoscopic Ultrasound-Guided Tissue Acquisition in Patients with Solid Pancreatic Lesions.

OBJECTIVES Remimazolam is an ultra-short-acting benzodiazepine with a shorter pharmacokinetic half-life than midazolam. This study compared the efficacy and safety of remimazolam and midazolam for sedation during endoscopic ultrasound-guided tissue acquisition (EUS-TA) in patients with solid pancreatic lesions. METHO...

Y. Tanisaka, S. Ryozawa, M. Mizuide et al. · 0 citations
Aug 2026

Comparative study on the efficacy and safety of remimazolam versus midazolam for sedation during ERCP-related procedures in the elderly.

Remimazolam significantly shortened recovery time and reduced flumazenil use in elderly patients, which may reduce staff workload after ERCP; larger studies are needed to establish comparative safety.

Suguru Ito, Y. Tanisaka, S. Ryozawa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.